Particle.news
Download on the App Store

Abel Steps Up Capital Deployment at Berkshire With Fresh Buying and $9.7 Billion OxyChem Deal

Heavy first‑quarter moves hint at a turn from Buffett’s three‑year selling streak.

Overview

  • Berkshire bought about $16 billion of stocks in the first quarter of 2026, sold more than $24 billion, and closed the $9.7 billion purchase of OxyChem.
  • Taken together, the stock purchases and the OxyChem deal outweighed equity sales, which may mark an end to Buffett’s 13‑quarter stretch of net selling.
  • Cash on hand stood near $400 billion at quarter‑end, giving Berkshire ample room to invest during market stress or to fund more deals.
  • New CEO Greg Abel told shareholders he will keep the conglomerate intact with a focused stock portfolio that still includes large stakes in American Express and Coca‑Cola.
  • Ted Weschler now runs a larger share of the portfolio after Todd Combs’s exit, a shift that likely contributed to the quarter’s heavier trading.